Variant report
Variant | nsv589292 |
---|---|
Chromosome Location | chr3:359160-378069 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:20)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:20 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr3:377988-378086 | H1-hESC | embryonic stem cell: | n/a | n/a |
2 | CTCF | chr3:360820-360858 | Kidney_OC | kidney: | n/a | n/a |
3 | EP300 | chr3:360589-360901 | SK-N-SH_RA | brain: | n/a | n/a |
4 | EP300 | chr3:360571-360892 | SK-N-SH_RA | brain: | n/a | n/a |
5 | EP300 | chr3:376998-377287 | SK-N-SH_RA | brain: | n/a | n/a |
6 | IRF1 | chr3:371993-372007 | K562 | blood: | n/a | n/a |
7 | MAFF | chr3:367223-367524 | HepG2 | liver: | n/a | chr3:367357-367375 |
8 | MAFF | chr3:367279-367485 | K562 | blood: | n/a | chr3:367357-367375 |
9 | MAFK | chr3:367250-367564 | K562 | blood: | n/a | chr3:367359-367374 |
10 | MAFK | chr3:367191-367549 | HepG2 | liver: | n/a | chr3:367359-367374 |
11 | MAFK | chr3:367204-367516 | HepG2 | liver: | n/a | chr3:367359-367374 |
12 | MAFK | chr3:367193-367554 | IMR90 | lung: | n/a | chr3:367359-367374 |
13 | MAFK | chr3:367282-367482 | H1-hESC | embryonic stem cell: | n/a | chr3:367359-367374 |
14 | POLR2A | chr3:377490-377521 | GM12878 | blood: | n/a | n/a |
15 | POLR2A | chr3:365910-366040 | GM12878 | blood: | n/a | n/a |
16 | POLR2A | chr3:367135-367326 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | RFX5 | chr3:371145-371169 | K562 | blood: | n/a | n/a |
18 | RFX5 | chr3:361455-361464 | K562 | blood: | n/a | n/a |
19 | STAT3 | chr3:369669-369759 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | ZC3H11A | chr3:366197-366400 | K562 | blood: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
CHL1 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs330900 | chr3:359160-359161 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs375395547 | chr3:359208-359209 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs114300093 | chr3:359225-359226 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs189982764 | chr3:359251-359252 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs79185595 | chr3:359252-359253 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs193184983 | chr3:359312-359313 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs370451186 | chr3:359332-359333 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs201105154 | chr3:359335-359336 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs35799872 | chr3:359337-359338 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs77110504 | chr3:359338-359339 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs71058763 | chr3:359350-359351 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs530043614 | chr3:359373-359374 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs528210098 | chr3:359375-359376 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs541608532 | chr3:359402-359403 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs185413928 | chr3:359412-359413 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs530349718 | chr3:359418-359419 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs372802028 | chr3:359419-359420 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs78344689 | chr3:359431-359432 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs4685578 | chr3:359454-359455 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs530763711 | chr3:359460-359461 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs552171683 | chr3:359474-359475 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs570586642 | chr3:359478-359479 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs561608468 | chr3:359481-359482 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs534774542 | chr3:359498-359499 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs189540046 | chr3:359557-359558 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs4685579 | chr3:359574-359575 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs142189541 | chr3:359600-359601 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs541258537 | chr3:359614-359615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs374857438 | chr3:359642-359643 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs180675854 | chr3:359647-359648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs116330921 | chr3:359668-359669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs545447336 | chr3:359676-359677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs557808118 | chr3:359768-359769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs572903299 | chr3:359788-359789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs540313644 | chr3:359795-359796 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs115258984 | chr3:359830-359831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs530226053 | chr3:359834-359835 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs146332403 | chr3:359863-359864 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs550148290 | chr3:359874-359875 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs547764587 | chr3:359886-359887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs563869209 | chr3:359889-359890 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs139574437 | chr3:359912-359913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs56270007 | chr3:359920-359921 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs528508697 | chr3:359924-359925 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs554796402 | chr3:359981-359982 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs546686869 | chr3:359982-359983 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs568543805 | chr3:360003-360004 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs377227267 | chr3:360022-360023 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs144306494 | chr3:360027-360028 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs539721711 | chr3:360028-360029 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Lung cancer | 16618734 | CNVD |
Autism | 18349135 | CNVD |
Breast cancer | 20409316 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 22241247 | CNVD |
Intellectual disability | 22045946 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
sporadic birth defects | 19047251 | CNVD |
Mental retardation | 17124404 | CNVD |
abnormal development | 18461090 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20967226 | CNVD |
Autism | 22543975 | CNVD |
Attention deficit hyperactivity disorder | 19546859 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 20685689 | CNVD |
Melanoma | 20877625 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:351000-369800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
2 | chr3:358800-359600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
3 | chr3:360000-391800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr3:365800-366000 | Enhancers | Brain Anterior Caudate | brain |
5 | chr3:366000-410400 | Weak transcription | Brain Anterior Caudate | brain |
6 | chr3:366200-376000 | Weak transcription | Ovary | ovary |
7 | chr3:367600-380400 | Weak transcription | Brain Germinal Matrix | brain |
8 | chr3:367800-375400 | Weak transcription | Fetal Brain Female | brain |
9 | chr3:368600-374400 | Weak transcription | Fetal Brain Male | brain |
10 | chr3:369800-371000 | Strong transcription | Breast Myoepithelial Primary Cells | Breast |
11 | chr3:370200-371000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
12 | chr3:371000-386200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
13 | chr3:374000-375200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
14 | chr3:374200-375000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
15 | chr3:374200-377800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
16 | chr3:374400-375800 | Enhancers | Fetal Brain Male | brain |
17 | chr3:374600-375400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
18 | chr3:375000-377000 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
19 | chr3:375400-375600 | Enhancers | Fetal Brain Female | brain |
20 | chr3:375600-389200 | Weak transcription | Fetal Brain Female | brain |
21 | chr3:377000-377400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
22 | chr3:377400-380200 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
23 | chr3:377800-380400 | Weak transcription | Cortex derived primary cultured neurospheres | brain |